Displaying 1021 - 1040 of 1097
PIP Number | Active Substance | Conditions / Indications | Invented Name | Therapeutic area | Decision Type | Compliance Check | Compliance outcome | Date Published Sort ascending |
---|---|---|---|---|---|---|---|---|
PIP Number MHRA-100391-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100392-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100164-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100168-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100163-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100157-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check Yes | Compliance outcome Full Compliance Check Granted | Date Published Sort ascending |
PIP Number MHRA-100156-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100155-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100147-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check Yes | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100119-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100118-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100107-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100090-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100089-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100084-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100112-PIP01-21 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100086-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100093-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100078-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100072-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |